Literature DB >> 1966546

Enhanced phosphorylation of 65 and 74 kDa proteins by tumor necrosis factor and interleukin-1 in human peripheral blood mononuclear cells.

M Shiroo1, K Matsushima.   

Abstract

Tumor necrosis factor (TNF) and interleukin-1 (IL-1) enhanced the phosphorylation of identical cytosolic 65 kDa protein (P65 or l-plastin) and 74 kDa protein (P74) at serine residues in human peripheral blood mononuclear cells (PBMC). The isoelectric points of P65 and P74 were 5.6 and 4.7 to 5.0, respectively. The phosphorylation of these proteins increased with a few minutes and reached maximal levels of approximately 3 times the unstimulated levels by 10 minutes. The phosphorylation of P65 and P74 was extensively enhanced by a potent protein kinase C (PKC) activator, PMA. However, there was no translocation of PKC from cytosol to membrane in PBMC that was stimulated with either TNF or IL-1, which suggests that PKC does not participate in TNF or IL-1 signal transduction. cAMP dependent protein (PKA) activators, forskolin and PGE2, failed to increase the phosphorylation, which is in agreement with the data showing that neither TNF nor IL-1 increased cAMP levels in PBMC. These results suggest that induction of phosphorylation of P65 and P74 by TNF and IL-1 is not mediated by PKC and PKA but may be mediated by another protein kinase and result in overlapping of biological activities between TNF and IL-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1966546     DOI: 10.1016/1043-4666(90)90038-u

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function.

Authors:  S L Jones; J Wang; C W Turck; E J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

2.  Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.

Authors:  Ziad Al Tanoury; Elisabeth Schaffner-Reckinger; Aliaksandr Halavatyi; Céline Hoffmann; Michèle Moes; Ermin Hadzic; Marie Catillon; Mikalai Yatskou; Evelyne Friederich
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

Review 3.  Tumor necrosis factor receptors--structure and function.

Authors:  J Rothe; G Gehr; H Loetscher; W Lesslauer
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

4.  Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669.

Authors:  M Kracht; M Shiroo; C J Marshall; J J Hsuan; J Saklatvala
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

5.  Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha.

Authors:  S Mathias; K A Dressler; R N Kolesnick
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Specific activation of beta-casein kinase by the inflammatory cytokines interleukin 1 and tumour necrosis factor.

Authors:  F Guesdon; R J Waller; J Saklatvala
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

7.  Investigation of guanine-nucleotide-binding protein involvement and regulation of cyclic AMP metabolism in interleukin 1 signal transduction.

Authors:  K Ray; N Thompson; N Kennard; P Rollins; S Grenfell; S Witham; N Smithers; R Solari
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Plastin family of actin-bundling proteins: its functions in leukocytes, neurons, intestines, and cancer.

Authors:  Hiroto Shinomiya
Journal:  Int J Cell Biol       Date:  2012-01-04

9.  The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner.

Authors:  Bassam Janji; Laurent Vallar; Ziad Al Tanoury; François Bernardin; Guillaume Vetter; Elisabeth Schaffner-Reckinger; Guy Berchem; Evelyne Friederich; Salem Chouaib
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.